Stellar Technologies, Inc.

Stellar Technologies, Inc. is engaged in the design and development of innovative medical devices, emphasizing minimally invasive solutions for various medical fields. The company partners with leading firms to address complex healthcare needs. Founded in 1993 and headquartered in Brooklyn Park, US, Stellar Technologies, Inc.

specializes in medical device solutions. The company was acquired by Cirtec Medical Systems, LLC in August 2016, as part of a strategic move to enhance their offerings in advanced medical technology. Brian Highley and Elizabeth Abraham are the current CEOs of the company. Stellar Technologies, Inc.

focuses on the design, development, and manufacturing of advanced medical devices tailored for minimally invasive procedures. The company's offerings include precision-engineered catheter systems and high-quality materials for implantable devices, catering to various medical fields such as cardiology and neurology. Stellar's products are marketed primarily in North America and Europe to hospitals and outpatient surgical centers, serving major medical device manufacturers. Stellar Technologies, Inc.

generates revenue through B2B transactions, collaborating with medical device manufacturers and healthcare providers. The company engages in direct sales of its specialized products, which include advanced catheter technologies. Revenue generation relies on custom agreements that ensure compliance with rigorous regulatory and performance standards, reinforcing its position as a reliable partner in the medical device sector. Following its acquisition in August 2016, Stellar Technologies, Inc.

plans to leverage its collaboration with Cirtec Medical Systems to enhance its product line and explore new markets. The company aims to introduce new product designs focused on advanced medical solutions, with anticipated launches in the coming years. Additionally, Stellar is targeting expansion into European and Asian markets to broaden its reach. The funding from Southfield Mezzanine Capital will support these initiatives, strengthening their competitive edge in the medical device industry.